Hospital Costa Del Sol

Hospital Costa Del Sol’s internal medicine team is leading studies in cardiovascular disease, targeting the primary prevention of atherosclerotic cardiovascular disease.

• Evaluation of a novel RNA‑based therapy to lower major adverse cardiac events
• Assessment of risk reduction in high‑risk primary prevention patients
• Investigation of long‑term safety and effectiveness of preventive treatment

The trials aim to demonstrate that new preventive strategies can lower the incidence of heart attacks, strokes, and related complications, offering safer options for patients at elevated cardiovascular risk.

The site is also active in cancer research, focusing on chronic lymphocytic leukemia in patients who have not received prior therapy.

• Comparison of continuous ibrutinib monotherapy with fixed‑duration venetoclax‑based regimens
• Measurement of progression‑free survival as a primary outcome
• Exploration of treatment sequencing to improve long‑term disease control

These studies seek to identify the most effective treatment approach for newly diagnosed CLL, potentially reducing disease progression and enhancing quality of life.